| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | NANOTOOLS BIOSCIENCE LLC | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43MH124563 | Non-genetic optical stimulation platform for the next-generation neuroscience drug discovery assays | 000 | 1 | NIH | 4/26/2024 | $0 |
| | 2024 | 2020 | NANOTOOLS BIOSCIENCE LLC | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43TR003252 | LightKick: Novel bioengineering system for activity-dependent acceleration of functional maturation of human stem cell-derived cardiomyocytes | 000 | 1 | NIH | 2/16/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2021 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43MH124563 | Non-genetic optical stimulation platform for the next-generation neuroscience drug discovery assays | 000 | 1 | NIH | 12/14/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2020 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43TR003252 | LightKick: Novel bioengineering system for activity-dependent acceleration of functional maturation of human stem cell-derived cardiomyocytes | 000 | 1 | NIH | 6/22/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $350,122 ) |
| | 2021 | 2021 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43MH124563 | Non-genetic optical stimulation platform for the next-generation neuroscience drug discovery assays | 000 | 1 | NIH | 12/18/2020 | $350,122 |
| | 2021 | 2017 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43TR001911 | Novel nanotechnology-based optical stimulation platform for predictive cardiotoxicity assessment | 000 | 1 | NIH | 2/21/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $325,036 ) |
| | 2020 | 2020 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43TR003252 | LightKick: Novel bioengineering system for activity-dependent acceleration of functional maturation of human stem cell-derived cardiomyocytes | 001 | 1 | NIH | 7/13/2020 | $0 |
| | 2020 | 2020 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43TR003252 | LightKick: Novel bioengineering system for activity-dependent acceleration of functional maturation of human stem cell-derived cardiomyocytes | 000 | 1 | NIH | 6/30/2020 | $325,036 |
| | 2020 | 2017 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43TR001911 | Novel nanotechnology-based optical stimulation platform for predictive cardiotoxicity assessment | 000 | 1 | NIH | 7/9/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43TR001911 | Novel nanotechnology-based optical stimulation platform for predictive cardiotoxicity assessment | 000 | 1 | NIH | 8/15/2019 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $325,000 ) |
| | 2017 | 2017 | NANOTOOLS BIOSCIENCE | 309 HESTIA WAY | ENCINITAS | CA | 92024-2179 | SAN DIEGO | USA | R43TR001911 | Novel nanotechnology-based optical stimulation platform for predictive cardiotoxicity assessment | 000 | 1 | NIH | 8/23/2017 | $325,000 |
|
|
